Wedbush lowered the firm’s price target on Xenon Pharmaceuticals (XENE) to $42 from $43 and keeps an Outperform rating on the shares. Most ...

Wells Fargo analyst Mohit Bansal maintained a Buy rating on Xenon (XENE – Research Report) today and set a price target of $50.00. The ...

Analyst firms have expressed optimism about Xenon's trajectory. H.C. Wainwright has maintained a Buy rating and a price target of $53.00 for Xenon, due to the potential of Azetukalner. RBC Capital ...

On Tuesday, Deutsche Bank (ETR:DBKGn) initiated coverage on Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy rating and a price target of $67.00, well above the current trading price of $39.25.

William Blair restated their outperform rating on shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) in a report ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) has earned an average rating of “Buy” from the nine ratings firms that are covering the company, Ratings reports. Nine equities research ...

The Tata Xenon is a pick-up truck manufactured by Tata Motors and is designed, developed and manufactured entirely in India. It provides ample amount of power and torque for all sorts of terrains.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...